Endo Pharmaceuticals

Infobox_Company
company_name = Endo Pharmaceuticals
company_
company_type = Public NYSE|ENDP
company_slogan =
foundation =
location = Chadds Ford, Pennsylvania
num_employees =
industry = Pharmaceuticals
products =
revenue =
net_income =
homepage = [http://www.endo.com/ www.endo.com]

Endo became Endo Pharmaceuticals Inc. as a result of a management buyout from DuPont Merck in 1997. Three DuPont Merck executives (Carol A. Ammon, Chairman, President & CEO, and Mariann T. MacDonald, Executive Vice President, Operations, along with another colleague) purchase all of Endo Laboratories L.L.C.'s generic products along with 12 important brand products, including Percocet® and Percodan®. The principals name their new company Endo Pharmaceuticals Inc.

Endo acquired Algos Pharmaceutical Corporation through a merger in July 2000 and began to trade publicly (NASDAQ: ENDP). Endo Pharmaceuticals successfully completed a secondary offering for a total of 12,925,000 shares of its common stock in Oct 2001. The net proceeds were used to pay existing bank debt.

Endo is a specialty pharmaceutical company engaged in the research, development, sale and marketing of prescription pharmaceuticals used primarily to treat and manage pain.

Endo rents some lab space from Novartis, at the Novartis production facility in Lincoln, Nebraska. At this lab, there is quality control testing of the Endo products that are produced on-site. At this particular Novartis production site, products such as TheraFlu, Triaminic and Buckley's are produced, as well as all of the Excedrin distributed across the entire nation.

Personnel

* Chief Executive officer: David P. Holveck (as of April 2008) ref_label|CEO|3|a
* Chief financial officer: Charles A. Rowland Jr. (Resigned Sept 2008) ref_label|CFO|3|a
* The company's sales force numbers 690 ref_label|CFO|1|b

Productsref_label|Products|2|a

* Amantadine (Symmetrel)
* Carbidopa with levodopa (Carbidopa/Levodopa USP)
* Frovatriptan (Frova)
* Hydrocodone with acetominophen (Zydone)
* Hydrocodone with homatropine (Hycodan)
* Lidocaine (Lidoderm)
** Lidocaine with tetracaine (Synera)
* Molindone (Moban)
* Oxycodone with acetominophen (Percocet, Endocet)
* Oxycodone with aspirin (Percodan)
* Oxymorphone (Opana)

References

#note_label|CFO|CFO|bcite news | author = Staff
title = Endo Pharmaceuticals names new CFO
url = http://www.delawareonline.com/apps/pbcs.dll/article?AID=/20061206/BUSINESS/61206053/-1/NLETTER02
publisher = Delaware News Journal
date = 2006-12-06 | accessdate = 2006-12-06
# cite web
url = http://www.endo.com/investor/products/listing.html
title = Product Listing
accessdate = 2006-12-06| year = 2006| publisher = Endo Pharmaceuticals
# cite web
url = http://phx.corporate-ir.net/phoenix.zhtml?c=123046&p=irol-news
title = Corporate Officers
accessdate = 2008-09-15| year = 2008| publisher = Endo Pharmaceuticals